Integrating Gene Expression With Recurrent Mutations Improves Age-Stratified Risk Prediction in Acute Myeloid Leukemia [0.03%]
结合基因表达与反复出现的突变可提高急性髓系白血病的风险预测
Mobina Shrestha,Salina Dahal,Asis Shrestha et al.
Mobina Shrestha et al.
Background: Older adults with acute myeloid leukemia (AML) have inferior outcomes, yet current genetic risk models do not explicitly account for how age modifies the prognostic impact of molecular features. We hypothesize...
Scleredema Associated With IgG/κ Monoclonal Gammopathy of Clinical Significance Successfully Treated With Daratumumab Monotherapy: A Case Report [0.03%]
一例具有临床意义的IgG / κ单克隆免疫球蛋白血症伴 scleredema患者采用Daratumumab单药治疗成功:病例报告
Davide Marcolongo,Alessandra Bressan,Elisabetta Zanatta et al.
Davide Marcolongo et al.
Background: Cutaneous monoclonal gammopathy of clinical significance (MGCS) is rare and may present with scleredema-like fibrosing skin disease. Case: ...
Myelodysplastic Syndrome (MDS) With KMT2A::CBL Rapidly Progressed to Acute Myeloid Leukaemia (AML) [0.03%]
KMT2A::CBL基因融合的骨髓增生异常综合征(MDS)快速进展为急性髓系白血病(AML)
Ke Xu,Temenuzhka Boneva,Elisabeth Nacheva
Ke Xu
Adenovirus-Associated Opsoclonus After Allogeneic Hematopoietic Stem Cell Transplantation [0.03%]
同种异基因造血干细胞移植后腺病毒相关的眼肌阵挛综合征病例报告
Toru Miyajima,Setsuaki Hoshino,Shingo Nojima et al.
Toru Miyajima et al.
Selumetinib as an Effective Therapy of Histiocytic Sarcoma Evolving From a B-Cell Acute Lymphoblastic Leukaemia [0.03%]
塞利米替尼治疗从B细胞急性淋巴细胞白血病演化而来的朗格汉斯组织细胞增生症效果显著
Laetitia Largeaud,Charlotte Syrykh,Julie Vial et al.
Laetitia Largeaud et al.
Introduction: Histiocytic sarcoma (HS) is a rare neoplasm derived from non-Langerhans histiocytic cells, exceptionally arising from B-ALL. Methods: ...
Global Burden of Sickle Cell Disease: Adequacy of Pain Control as Evidenced by Frequency of Oral Pain Medication Use, Health Outcomes, and Emotional Well-Being Across Diverse Populations [0.03%]
全球镰状细胞病负担:由口服止痛药使用频率、健康结果和情感幸福感所证明的疼痛控制充分性在不同人群中的差异
Akshat Jain,Lisa Roberts,Safiye Sahin
Akshat Jain
Introduction: Sickle cell disease (SCD) is a chronic genetic disorder causing severe pain, anemia, and systemic complications that negatively affect patients' physical and mental well-being. The aim of this global cross-s...
Liver Cirrhosis and In-Hospital Outcomes in Patients With Sickle Cell Crises [0.03%]
肝硬化与镰状细胞病危重患者的院内结局关系研究
Shakirat Gold-Olufadi,Kayode Ogunniyi,Adeleke Oluwaseun Dorcas et al.
Shakirat Gold-Olufadi et al.
Introduction: Sickle cell disease (SCD) is a hematologic disorder characterized by chronic hemolysis, vaso-occlusion, and end-organ dysfunction. Patients with SCD may experience acute episodes known as sickle cell crises,...
Haploidentical Hematopoietic Stem Cell Transplantation With Anti-Thymocyte Globulin in the Treatment of Older Adults With Hematological Malignancy [0.03%]
抗胸腺细胞免疫球蛋白在非全合造血干细胞移植治疗老年血液系统恶性肿瘤中的应用研究
Xin Kong,Jingjing Han,Yin Liu et al.
Xin Kong et al.
Objectives: Studies on the efficacy and safety of haploidentical hematopoietic stem cell transplantation (haplo-SCT) with anti-thymocyte globulin (ATG) in patients aged ≥ 60 years remain limited. ...
Real-World Analysis of Outcomes of Venetoclax+Azacitidine Versus 7+3 Induction in Acute Myeloid Leukemia [0.03%]
维奈克拉联合地西他滨与柔红霉素联合阿糖胞苷诱导治疗急性髓系白血病的预后分析
Nehemias Guevara Rodriguez,Noemy Coreas Mercado,Syeda Ashna Fatima Kamal et al.
Nehemias Guevara Rodriguez et al.
Background: Venetoclax plus azacitidine (V+A) is standard for older, intensive-ineligible patients with acute myeloid leukemia (AML). Its expanding use in younger, curative-eligible adults lacks comparative evidence again...
Identification of a Novel, Oncogenic and Targetable TPR::ABL2 Fusion Gene in T-Cell Acute Lymphoblastic Leukaemia [0.03%]
T细胞急性淋巴细胞白血病中发现一种新的致癌且可药靶向的TPR::ABL2融合基因
Elias Lagonik,Elyse C Page,Laura N Eadie et al.
Elias Lagonik et al.
ABL2 rearrangements represent a subtype of acute lymphoblastic leukaemia (ALL) associated with poor prognosis and survival. This study reports a high-risk T-cell ALL (T-ALL) case with a novel TPR::ABL2 gene fusion resulting from a chromosom...